University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.
Features
Evolution of urinalysis: the journey from dipstick to digital solution
Julie Elston provides an insight into the evolution of urinalysis. She argues that digital solutions could address some of the issues associated with urinalysis – such as improper handling, inconsistent dip times, subjective interpretation, and inefficient processes.
Early-onset colorectal cancer: an increasing healthcare issue
Historically, colorectal cancer was seen as a disease of later life. More recently, however, the increased incidence of cancer affecting the lower intestinal tract in the younger age group has been reported. Here, Pathology in Practice Science Editor Brian Nation looks at a selection of current research focusing on this emerging healthcare...
Products
New LIAISON tuberculosis assay improves efficiency and productivity
Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.
Menarini introduces Coyote FlashDetect PCR device range
Menarini has added Coyote FlashDetect PCR to its range of diagnostic solutions. These scalable rapid PCR devices will enable users to gain high quality results within 35 minutes.
QIAGEN unveils QIAsymphony Connect at AMP 2025
QIAGEN has launched QIAsymphony Connect, the next generation of its widely adopted automated nucleic acid purification platform, at the 2025 AMP (Association for Molecular Pathology) annual meeting.
ProtonDx's Dragonfly evaluated for identifying hidden malaria cases
A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.
Latest Issues
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
Cell & Gene Therapy 2026
Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026
UK NEQAS webinar: Specialist Demonstration of Lipids, Pigments, Minerals, and Infections
Online
10-11 March, 2026
USCAP 115th Annual Meeting
Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026
Analytica 2026
Messe München, Munich, Germany
24-27 March, 2026
Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
7 April, 2026